BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alkhalaf M, Jaffal S. Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade. Free Radic Biol Med 2006;41:318-25. [PMID: 16814113 DOI: 10.1016/j.freeradbiomed.2006.04.019] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Castañeda AM, Meléndez CM, Uribe D, Pedroza-Díaz J. Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies. Heliyon 2022;8:e09519. [PMID: 35669542 DOI: 10.1016/j.heliyon.2022.e09519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen S, Zeng J, Huang L, Peng Y, Yan Z, Zhang A, Zhao X, Li J, Zhou Z, Wang S, Jing S, Hu M, Li Y, Wang D, Wang W, Yu H, Miao J, Li J, Deng Y, Li Y, Liu T, Xu D. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma. J Transl Med 2022;20:228. [PMID: 35568866 DOI: 10.1186/s12967-022-03415-6] [Reference Citation Analysis]
3 De Luca A, Bellavia D, Raimondi L, Carina V, Costa V, Fini M, Giavaresi G. Multiple Effects of Resveratrol on Osteosarcoma Cell Lines. Pharmaceuticals 2022;15:342. [DOI: 10.3390/ph15030342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 G MS, Swetha M, Keerthana CK, Rayginia TP, Anto RJ. Cancer Chemoprevention: A Strategic Approach Using Phytochemicals. Front Pharmacol 2021;12:809308. [PMID: 35095521 DOI: 10.3389/fphar.2021.809308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Rabelo ACS, Borghesi J, Noratto GD. The role of dietary polyphenols in osteosarcoma: A possible clue about the molecular mechanisms involved in a process that is just in its infancy. J Food Biochem 2021;:e14026. [PMID: 34873724 DOI: 10.1111/jfbc.14026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Tobeiha M, Rajabi A, Raisi A, Mohajeri M, Yazdi SM, Davoodvandi A, Aslanbeigi F, Vaziri M, Hamblin MR, Mirzaei H. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms. Biomed Pharmacother 2021;144:112257. [PMID: 34688081 DOI: 10.1016/j.biopha.2021.112257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zahedipour F, Bolourinezhad M, Teng Y, Sahebkar A. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art. J Oncol 2021;2021:3006853. [PMID: 34671398 DOI: 10.1155/2021/3006853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li G, Peng X, Guo Y, Gong S, Cao S, Qiu F. Currently Available Strategies for Target Identification of Bioactive Natural Products. Front Chem 2021;9:761609. [PMID: 34660543 DOI: 10.3389/fchem.2021.761609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Aktepe N, Yukselten Y. Induction of apoptosis in human hormone-refractory prostate cancer cell lines by using resveratrol in combination with AT-101. Andrologia 2021;:e14267. [PMID: 34633104 DOI: 10.1111/and.14267] [Reference Citation Analysis]
10 Akter R, Rahman MH, Kaushik D, Mittal V, Uivarosan D, Nechifor AC, Behl T, Karthika C, Stoicescu M, Munteanu MA, Bustea C, Bungau S. Chemo-Preventive Action of Resveratrol: Suppression of p53-A Molecular Targeting Approach. Molecules 2021;26:5325. [PMID: 34500758 DOI: 10.3390/molecules26175325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Zou J, Du J, Tu H, Chen H, Cong K, Bi Z, Sun J. Resveratrol benefits the lineage commitment of bone marrow mesenchymal stem cells into osteoblasts via miR-320c by targeting Runx2. J Tissue Eng Regen Med 2021;15:347-60. [PMID: 33481337 DOI: 10.1002/term.3176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ma Z, Fan Y, Wu Y, Kebebe D, Zhang B, Lu P, Pi J, Liu Z. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment. Int J Nanomedicine 2019;14:2029-53. [PMID: 30962686 DOI: 10.2147/IJN.S197889] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
13 Jiang M, Wang Y, Xu N, Zhou L, An Q. Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs. J Cell Biochem 2019;120:5151-9. [DOI: 10.1002/jcb.27791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
14 Zhang Y, Yang F. Analyzing the disease module associated with osteosarcoma via a network- and pathway-based approach. Exp Ther Med 2018;16:2584-92. [PMID: 30210606 DOI: 10.3892/etm.2018.6506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Chen G, Xia H, Zhang ZG, Yu HL. Resveratrol in management of bone and spinal cancers. Nat Prod Res 2019;33:516-26. [PMID: 29052449 DOI: 10.1080/14786419.2017.1389936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Ferraz da Costa DC, Fialho E, Silva JL. Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target. Molecules 2017;22:E1014. [PMID: 28629161 DOI: 10.3390/molecules22061014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
17 Hu S, Li X, Xu R, Ye L, Kong H, Zeng X, Wang H, Xie W. The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells. Acta Biochim Biophys Sin (Shanghai) 2016;48:528-35. [PMID: 27084520 DOI: 10.1093/abbs/gmw026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
18 Risuleo G. Resveratrol. Nutraceuticals 2016. [DOI: 10.1016/b978-0-12-802147-7.00033-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
19 Zou Y, Yang J, Jiang D. Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells. Mol Med Rep 2015;12:7221-6. [PMID: 26398440 DOI: 10.3892/mmr.2015.4338] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
20 Lephart ED. Polyphenols and Cognitive Function. Diet and Exercise in Cognitive Function and Neurological Diseases 2015. [DOI: 10.1002/9781118840634.ch14] [Reference Citation Analysis]
21 Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des. 2013;19:6064-6093. [PMID: 23448440 DOI: 10.2174/13816128113199990407] [Cited by in Crossref: 308] [Cited by in F6Publishing: 324] [Article Influence: 34.2] [Reference Citation Analysis]
22 Spina A, Sorvillo L, Di Maiolo F, Esposito A, D’Auria R, Di Gesto D, Chiosi E, Naviglio S. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J Cell Physiol. 2013;228:198-206. [PMID: 22674530 DOI: 10.1002/jcp.24124] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
23 Ortega I, Wong DH, Villanueva JA, Cress AB, Sokalska A, Stanley SD, Duleba AJ. Effects of resveratrol on growth and function of rat ovarian granulosa cells. Fertil Steril 2012;98:1563-73. [PMID: 22959450 DOI: 10.1016/j.fertnstert.2012.08.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
24 Heo JI, Oh SJ, Kho YJ, Kim JH, Kang HJ, Park SH, Kim HS, Shin JY, Kim MJ, Kim M, Kim SC, Park JB, Kim J, Lee JY. ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damage. Mol Biol Rep 2012;39:8007-14. [PMID: 22576881 DOI: 10.1007/s11033-012-1647-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
25 Goswami RK, Bajjuri KM, Forsyth JS, Das S, Hassenpflug W, Huang ZZ, Lerner RA, Felding-Habermann B, Sinha SC. Chemically programmed antibodies targeting multiple alpha(v) integrins and their effects on tumor-related functions in vitro. Bioconjug Chem 2011;22:1535-44. [PMID: 21774545 DOI: 10.1021/bc2000879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
26 Mehdawi H, Alkhalaf M, Khan I. Role of Na+/H+ exchanger in resveratrol-induced growth inhibition of human breast cancer cells. Med Oncol 2012;29:25-32. [DOI: 10.1007/s12032-010-9786-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
27 Cheng Y, Qiu F, Ye YC, Tashiro S, Onodera S, Ikejima T. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells. Arch Biochem Biophys. 2009;490:70-75. [PMID: 19699177 DOI: 10.1016/j.abb.2009.08.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
28 Goswami SK, Das DK. Resveratrol and chemoprevention. Cancer Lett. 2009;284:1-6. [PMID: 19261378 DOI: 10.1016/j.canlet.2009.01.041] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 8.1] [Reference Citation Analysis]
29 Lee HP, Zhu X, Zhu X, Skidmore SC, Perry G, Sayre LM, Smith MA, Lee HG. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells. J Neurochem 2009;108:1434-41. [PMID: 19183271 DOI: 10.1111/j.1471-4159.2009.05883.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
30 Pezzuto JM. Resveratrol as an Inhibitor of Carcinogenesis. Pharmaceutical Biology 2008;46:443-573. [DOI: 10.1080/13880200802116610] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
31 Liu J, Mao W, Ding B, Liang CS. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295:H1956-65. [PMID: 18775851 DOI: 10.1152/ajpheart.00407.2008] [Cited by in Crossref: 178] [Cited by in F6Publishing: 188] [Article Influence: 11.9] [Reference Citation Analysis]
32 Venkatesan B, Ghosh-Choudhury N, Das F, Mahimainathan L, Kamat A, Kasinath BS, Abboud HE, Choudhury GG. Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J 2008;22:3469-82. [PMID: 18567737 DOI: 10.1096/fj.08-109488] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
33 Lin T, Mak N, Yang M. MAPK regulate p53-dependent cell death induced by benzo[a]pyrene: Involvement of p53 phosphorylation and acetylation. Toxicology 2008;247:145-53. [DOI: 10.1016/j.tox.2008.02.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
34 Saracino MR, Lampe JW. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention. Nutr Cancer 2007;59:121-41. [PMID: 18001207 DOI: 10.1080/01635580701458178] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
35 Alkhalaf M, El-Mowafy A, Renno W, Rachid O, Ali A, Al-Attyiah R. Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Arch Med Res 2008;39:162-8. [PMID: 18164959 DOI: 10.1016/j.arcmed.2007.09.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
36 Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 2007;16:1753-73. [PMID: 17970636 DOI: 10.1517/13543784.16.11.1753] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 6.3] [Reference Citation Analysis]
37 Lee CH, Jeon YT, Kim SH, Song YS. NF-kappaB as a potential molecular target for cancer therapy. Biofactors. 2007;29:19-35. [PMID: 17611291 DOI: 10.1002/biof.5520290103] [Cited by in Crossref: 188] [Cited by in F6Publishing: 198] [Article Influence: 11.8] [Reference Citation Analysis]
38 Alkhalaf M. Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells. Pharmacology. 2007;80:134-143. [PMID: 17534123 DOI: 10.1159/000103253] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]